Vivani Medical (VANI) Competitors

$1.28 -0.11 (-7.91%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$1.28 +0.00 (+0.39%)

As of 07/24/2026 07:34 PM Eastern

VANI vs. COCH, CLPT, DCTH, SI, and ELMD

Should you buy Vivani Medical stock or one of its competitors? MarketBeat compares Vivani Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Vivani Medical include Envoy Medical (COCH), ClearPoint Neuro (CLPT), Delcath Systems (DCTH), Shoulder Innovations (SI), and Electromed (ELMD). These companies are all part of the "medical equipment" industry.

How does Vivani Medical compare to Envoy Medical?

Envoy Medical (NASDAQ:COCH) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 7.1% of Envoy Medical shares are owned by insiders. Comparatively, 53.3% of Vivani Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Envoy Medical had 2 more articles in the media than Vivani Medical. MarketBeat recorded 3 mentions for Envoy Medical and 1 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 1.89 beat Envoy Medical's score of 0.09 indicating that Vivani Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Envoy Medical	Neutral
Vivani Medical	Very Positive

Envoy Medical has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market. Comparatively, Vivani Medical has a beta of 2.33, meaning that its stock price is 133% more volatile than the broader market.

Envoy Medical currently has a consensus target price of $2.50, indicating a potential upside of 277.24%. Vivani Medical has a consensus target price of $3.75, indicating a potential upside of 192.97%. Given Envoy Medical's higher possible upside, equities research analysts plainly believe Envoy Medical is more favorable than Vivani Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Envoy Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$234K	217.73	-$23.76M	-$1.01	N/A
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A

Vivani Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
Vivani Medical	N/A	-264.04%	-79.85%

Summary

Vivani Medical beats Envoy Medical on 8 of the 15 factors compared between the two stocks.

How does Vivani Medical compare to ClearPoint Neuro?

Vivani Medical (NASDAQ:VANI) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by insiders. Comparatively, 6.9% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Vivani Medical presently has a consensus price target of $3.75, suggesting a potential upside of 192.97%. ClearPoint Neuro has a consensus price target of $23.00, suggesting a potential upside of 62.89%. Given Vivani Medical's higher possible upside, equities research analysts plainly believe Vivani Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Vivani Medical has a net margin of 0.00% compared to ClearPoint Neuro's net margin of -71.57%. ClearPoint Neuro's return on equity of -140.96% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
ClearPoint Neuro	-71.57%	-140.96%	-36.98%

In the previous week, ClearPoint Neuro had 1 more articles in the media than Vivani Medical. MarketBeat recorded 2 mentions for ClearPoint Neuro and 1 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 1.89 beat ClearPoint Neuro's score of 0.85 indicating that Vivani Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Vivani Medical	Very Positive
ClearPoint Neuro	Positive

ClearPoint Neuro has higher revenue and earnings than Vivani Medical. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
ClearPoint Neuro	$40.61M	10.43	-$25.54M	-$1.01	N/A

Vivani Medical has a beta of 2.33, meaning that its share price is 133% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market.

Summary

Vivani Medical and ClearPoint Neuro tied by winning 7 of the 14 factors compared between the two stocks.

How does Vivani Medical compare to Delcath Systems?

Vivani Medical (NASDAQ:VANI) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by insiders. Comparatively, 19.4% of Delcath Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Vivani Medical presently has a consensus price target of $3.75, suggesting a potential upside of 192.97%. Delcath Systems has a consensus price target of $22.17, suggesting a potential upside of 81.40%. Given Vivani Medical's higher possible upside, equities research analysts plainly believe Vivani Medical is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Delcath Systems has a net margin of 0.62% compared to Vivani Medical's net margin of 0.00%. Delcath Systems' return on equity of 0.51% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
Delcath Systems	0.62%	0.51%	0.46%

In the previous week, Delcath Systems had 1 more articles in the media than Vivani Medical. MarketBeat recorded 2 mentions for Delcath Systems and 1 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 1.89 beat Delcath Systems' score of 0.94 indicating that Vivani Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Vivani Medical	Very Positive
Delcath Systems	Positive

Delcath Systems has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
Delcath Systems	$90.44M	4.66	$2.70M	$0.01	1,222.00

Vivani Medical has a beta of 2.33, meaning that its share price is 133% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market.

Summary

Delcath Systems beats Vivani Medical on 11 of the 15 factors compared between the two stocks.

How does Vivani Medical compare to Shoulder Innovations?

Vivani Medical (NASDAQ:VANI) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

Vivani Medical has higher earnings, but lower revenue than Shoulder Innovations. Vivani Medical is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
Shoulder Innovations	$47.32M	8.95	-$40.36M	-$166.96	N/A

Vivani Medical has a net margin of 0.00% compared to Shoulder Innovations' net margin of -81.78%. Shoulder Innovations' return on equity of -35.11% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

In the previous week, Shoulder Innovations had 1 more articles in the media than Vivani Medical. MarketBeat recorded 2 mentions for Shoulder Innovations and 1 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 1.89 beat Shoulder Innovations' score of 1.00 indicating that Vivani Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Vivani Medical	Very Positive
Shoulder Innovations	Positive

Vivani Medical currently has a consensus price target of $3.75, suggesting a potential upside of 192.97%. Shoulder Innovations has a consensus price target of $21.00, suggesting a potential upside of 2.84%. Given Vivani Medical's higher probable upside, research analysts plainly believe Vivani Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

6.8% of Vivani Medical shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by company insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Vivani Medical and Shoulder Innovations tied by winning 7 of the 14 factors compared between the two stocks.

How does Vivani Medical compare to Electromed?

Vivani Medical (NASDAQ:VANI) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

Vivani Medical presently has a consensus target price of $3.75, indicating a potential upside of 192.97%. Electromed has a consensus target price of $37.50, indicating a potential downside of 2.37%. Given Vivani Medical's higher possible upside, equities analysts clearly believe Vivani Medical is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Electromed has a net margin of 11.34% compared to Vivani Medical's net margin of 0.00%. Electromed's return on equity of 15.71% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
Electromed	11.34%	15.71%	13.37%

In the previous week, Vivani Medical had 1 more articles in the media than Electromed. MarketBeat recorded 1 mentions for Vivani Medical and 0 mentions for Electromed. Vivani Medical's average media sentiment score of 1.89 beat Electromed's score of 0.00 indicating that Vivani Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Vivani Medical	Very Positive
Electromed	Neutral

Electromed has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
Electromed	$71.75M	4.43	$5.15M	$1.17	32.83

6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 53.3% of Vivani Medical shares are held by insiders. Comparatively, 10.5% of Electromed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Vivani Medical has a beta of 2.33, indicating that its share price is 133% more volatile than the broader market. Comparatively, Electromed has a beta of 0.5, indicating that its share price is 50% less volatile than the broader market.

Summary

Electromed beats Vivani Medical on 10 of the 15 factors compared between the two stocks.

Get Vivani Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VANI vs. The Competition

Export

Metric	Vivani Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$110.38M	$3.06B	$6.86B	$12.25B
Dividend Yield	N/A	2.07%	2.67%	9.79%
P/E Ratio	-3.20	20.29	27.14	23.64
Price / Sales	N/A	485.21	517.01	89.03
Price / Cash	N/A	27.62	50.54	59.64
Price / Book	6.40	4.13	10.28	6.07
Net Income	-$26.61M	$65.94M	$3.60B	$331.99M
7 Day Performance	-3.03%	-4.16%	-1.27%	-0.63%
1 Month Performance	12.28%	-3.76%	-0.37%	-2.00%
1 Year Performance	-20.50%	9.94%	18.30%	13.62%

Vivani Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VANI Vivani Medical	4.2793 of 5 stars	$1.28 -7.9%	$3.75 +193.0%	-20.0%	$110.38M	N/A	N/A	20
COCH Envoy Medical	3.1869 of 5 stars	$0.72 -4.6%	$2.50 +245.5%	-59.3%	$55.62M	$234K	N/A	34	News Coverage Upcoming Earnings Analyst Forecast Gap Up High Trading Volume
CLPT ClearPoint Neuro	2.7618 of 5 stars	$15.67 -1.8%	$23.00 +46.8%	+25.2%	$469.94M	$36.97M	N/A	110	News Coverage
DCTH Delcath Systems	2.702 of 5 stars	$13.18 +0.3%	$22.17 +68.2%	+7.2%	$454.97M	$85.23M	1,318.00	60	News Coverage
SI Shoulder Innovations	1.6475 of 5 stars	$21.82 +1.0%	$21.00 -3.7%	N/A	$452.42M	$53.89M	N/A	61

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VANI) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vivani Medical (VANI) Competitors

VANI vs. COCH, CLPT, DCTH, SI, and ELMD

How does Vivani Medical compare to Envoy Medical?

Summary

How does Vivani Medical compare to ClearPoint Neuro?

Summary

How does Vivani Medical compare to Delcath Systems?

Summary

How does Vivani Medical compare to Shoulder Innovations?

Summary

How does Vivani Medical compare to Electromed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI vs. The Competition

Vivani Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Vivani Medical (VANI) Competitors

VANI vs. COCH, CLPT, DCTH, SI, and ELMD

How does Vivani Medical compare to Envoy Medical?

Do insiders & institutionals believe in COCH or VANI?

Does the media refer more to COCH or VANI?

Which has more volatility & risk, COCH or VANI?

Do analysts prefer COCH or VANI?

Which has stronger earnings & valuation, COCH or VANI?

Is COCH or VANI more profitable?

Summary

How does Vivani Medical compare to ClearPoint Neuro?

Do insiders and institutionals hold more shares of VANI or CLPT?

Do analysts recommend VANI or CLPT?

Is VANI or CLPT more profitable?

Does the media prefer VANI or CLPT?

Which has better earnings & valuation, VANI or CLPT?

Which has more risk & volatility, VANI or CLPT?

Summary

How does Vivani Medical compare to Delcath Systems?

Do insiders and institutionals hold more shares of VANI or DCTH?

Do analysts recommend VANI or DCTH?

Is VANI or DCTH more profitable?

Does the media prefer VANI or DCTH?

Which has better earnings & valuation, VANI or DCTH?

Which has more risk & volatility, VANI or DCTH?

Summary

How does Vivani Medical compare to Shoulder Innovations?

Which has preferable earnings and valuation, VANI or SI?

Is VANI or SI more profitable?

Does the media favor VANI or SI?

Do analysts prefer VANI or SI?

Do institutionals and insiders hold more shares of VANI or SI?

Summary

How does Vivani Medical compare to Electromed?

Do analysts prefer VANI or ELMD?

Is VANI or ELMD more profitable?

Does the media favor VANI or ELMD?

Which has higher valuation and earnings, VANI or ELMD?

Do institutionals and insiders believe in VANI or ELMD?

Which has more risk and volatility, VANI or ELMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI vs. The Competition

Vivani Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools